BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29909887)

  • 1. Smoking impact on HPV driven head and neck cancer's oncological outcomes?
    Mirghani H; Leroy C; Chekourry Y; Casiraghi O; Aupérin A; Tao Y; Nguyen F; Caroline E; Breuskin I; Plana AM; Hartl D; Janot F; Temam S; Gorphe P; Blanchard P
    Oral Oncol; 2018 Jul; 82():131-137. PubMed ID: 29909887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
    Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
    Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
    Schroeder L; Pring M; Ingarfield K; Pawlita M; Leary SD; Thomas SJ; Waylen A; Waterboer T; Ness AR
    Oral Oncol; 2020 Aug; 107():104721. PubMed ID: 32361566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
    Tribius S; Hoffmann AS; Bastrop S; Görögh T; Haag J; Röcken C; Clauditz T; Grob T; Wilczak W; Tennstedt P; Borcherding A; Petersen C; Hoffmann M
    Oral Oncol; 2012 Nov; 48(11):1178-84. PubMed ID: 22739067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
    Vawda N; Banerjee RN; Debenham BJ
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and other patient factors in HPV-mediated oropharynx cancer: A retrospective cohort study.
    Schostag K; Lynch PT; Leavitt T; Sumer BD; Yang A; Shah A; Emmet TR; Sher DJ; Day AT
    Am J Otolaryngol; 2022; 43(5):103555. PubMed ID: 36037765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma.
    Martel M; Alemany L; Taberna M; Mena M; Tous S; Bagué S; Castellsagué X; Quer M; León X
    Oral Oncol; 2017 Jan; 64():37-43. PubMed ID: 28024722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
    O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
    J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.
    Lacau St Guily J; Rousseau A; Baujat B; Périé S; Schultz P; Barry B; Dufour X; Malard O; Pretet JL; Clavel C; Birembaut P; Franceschi S;
    Oral Oncol; 2017 Apr; 67():29-36. PubMed ID: 28351578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Papillomavirus and head and neck cancer].
    Lescaille G; Descroix V; Azérad J
    Rev Stomatol Chir Maxillofac; 2011 Jun; 112(3):160-3. PubMed ID: 21596407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
    Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
    Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of oropharyngeal cancer survival in Europe.
    Anantharaman D; Billot A; Waterboer T; Gheit T; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Polesel J; Simonato L; Alemany L; Mena Cervigon M; Macfarlane TV; Znaor A; Thomson PJ; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner ME; Pawlita M; Tommasino M; Brennan P
    Oral Oncol; 2018 Jun; 81():89-94. PubMed ID: 29884419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
    Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
    Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human papillomavirus and smoking on survival outcomes after transoral robotic surgery.
    Stucken CL; de Almeida JR; Sikora AG; Tong CC; Genden EM
    Head Neck; 2016 Mar; 38(3):380-6. PubMed ID: 25351893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
    Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
    Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.